ZFIN ID: ZDB-PUB-130416-10
MYCN Transgenic Zebrafish Model with the Characterization of Acute Myeloid Leukemia and Altered Hematopoiesis
Shen, L.J., Chen, F.Y., Zhang, Y., Cao, L.F., Kuang, Y., Zhong, M., Wang, T., and Zhong, H.
Date: 2013
Source: PLoS One   8(3): e59070 (Journal)
Registered Authors: Chen, Fangyuan, Shen, Li-Jing
Keywords: none
MeSH Terms:
  • Animals
  • Animals, Genetically Modified
  • Blood Cells/pathology
  • Cell Cycle/genetics
  • Cell Lineage/genetics
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation, Developmental
  • Gene Regulatory Networks
  • Genes, myc*
  • Genetic Vectors
  • Hematopoiesis/genetics*
  • Hematopoietic Stem Cells/pathology
  • Humans
  • Leukemia, Myeloid, Acute/genetics*
  • Leukemia, Myeloid, Acute/pathology
  • Male
  • Mice
  • Myeloid Cells/metabolism
  • Myeloid Cells/pathology
  • Transcription Factors/genetics
  • Transcription Factors/metabolism
  • Transcription, Genetic
  • Zebrafish
PubMed: 23554972 Full text @ PLoS One
FIGURES
ABSTRACT

Background

Amplification of MYCN (N-Myc) oncogene has been reported as a frequent event and a poor prognostic marker in human acute myeloid leukemia (AML). The molecular mechanisms and transcriptional networks by which MYCN exerts its influence in AML are largely unknown.

Methodology/Principal Findings

We introduced murine MYCN gene into embryonic zebrafish through a heat-shock promoter and established the stable germline Tg(MYCN:HSE:EGFP) zebrafish. N-Myc downstream regulated gene 1 (NDRG1), negatively controlled by MYCN in human and functionally involved in neutrophil maturation, was significantly under-expressed in this model. Using peripheral blood smear detection, histological section and flow cytometric analysis of single cell suspension from kidney and spleen, we found that MYCN overexpression promoted cell proliferation, enhanced the repopulating activity of myeloid cells and the accumulation of immature hematopoietic blast cells. MYCN enhanced primitive hematopoiesis by upregulating scl and lmo2 expression and promoted myelopoiesis by inhibiting gata1 expression and inducing pu.1, mpo expression. Microarray analysis identified that cell cycle, glycolysis/gluconeogenesis, MAPK/Ras, and p53-mediated apoptosis pathways were upregulated. In addition, mismatch repair, transforming and growth factor β (TGFβ) were downregulated in MYCN-overexpressing blood cells (p<0.01). All of these signaling pathways are critical in the proliferation and malignant transformation of blood cells.

Conclusion/Significance

The above results induced by overexpression of MYCN closely resemble the main aspects of human AML, suggesting that MYCN plays a role in the etiology of AML. MYCN reprograms hematopoietic cell fate by regulating NDRG1 and several lineage-specific hematopoietic transcription factors. Therefore, this MYCN transgenic zebrafish model facilitates dissection of MYCN-mediated signaling in vivo, and enables high-throughput scale screens to identify the potential therapeutic targets.

ADDITIONAL INFORMATION